Delivery of child-friendly antimalarial hits the 100 million mark
Wednesday, February 22, 2012 - 10:04
in Health & Medicine
One hundred million treatments of Coartem Dispersible (artemether-lumefantrine), an antimalarial developed especially for children with Plasmodium falciparum malaria, have been delivered by Novartis to 39 malaria-endemic countries, Medicines for Malaria Venture (MMV) announced today.